67 results

shutterstock_210964246
COVID-19

Posted on 26.10.2020

The implications of COVID-19 on recruiting in the Life Science sector

We’re at the heart of the global response to COVID-19, a powerful reminder of our mission to enable our customers to make the world healthier,cleaner and safer. What’s driving us every day is the feeling that there is a meaning to our work over and beyond the reward of the paycheck. What’s compelling now is […]

By Noel Brown Global Head of Talent Attraction & Acquisition at Thermo Fisher Scientific

shutterstock_1498583432
Research & Innovation

Posted on 21.09.2020

EU Health PPP: a new era for medtech companies

For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell.  This reality […]

By Philippe Cleuziat Senior Director, R&D Department Open Innovation & Partnerships at bioMerieux

shutterstock_768013051
COVID-19

Posted on 03.09.2020

COVID-19 & diagnostics: lessons on how to extract value from data

This is the second in a two-part series. Read part one. The link between clinical and social aspects of COVID-19 raises the question of what type of data are needed to manage the COVID-19 surge and better absorb shocks that may be caused by future pandemics.  We believe clinical patient level data are essential given […]

By Hans Martens Chair of the Coalition for Health, Ethics and Society (CHES), and former CEO of the European Policy Centre (EPC)

shutterstock_262883918
COVID-19

Posted on 27.08.2020

COVID-19 & diagnostics: the value of ‘test, test, test’

The power of diagnostics information (VODI) to public health and society was a topic of keen interest even before the COVID-19 outbreak. The pandemic offers us fresh lessons on how health systems can harness this value.  Many of us will recall one of the earliest recommendation from the Director General of the WHO during the […]

By Hans Martens Chair of the Coalition for Health, Ethics and Society (CHES), and former CEO of the European Policy Centre (EPC)

R&I in medtech shaping Europe’s heathcare and economyb
Research & Innovation

Posted on 22.05.2020

Closing the innovation loop: how start-ups can show value

One of my great frustrations is to see start-ups fall at the final hurdle. Too many early-stage companies with promising innovations spend their energy – and funds – answering crucial questions about the safety and effectiveness of their products, only to find that they have no answers to the additional questions asked by payers.   […]

By Furio Gramatica Director of Development & Innovation at Don Gnocchi Foundation

shutterstock_1680760828
COVID-19

Posted on 20.05.2020

Medtech role in the global response to the COVID-19

This blog is part of a blog series that showcases the medtech role in the different phases of the COVID-19 pandemic. Read here more COVID-19 related blogs. More info on MedTech Europe’s info hub.  The medical technology industry have played a pivotal role in the global response to the COVID-19 pandemic. Now it will be central […]

By Tanja Valentin Director External Affairs, MedTech Europe

slider-website-April-2020-VODI-HF
Access

Posted on 29.04.2020

Maximising the potential of diagnostic information in heart failure care

Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]

By Ed Harding Network Director, Heart Failure Policy Network - Co-founder and Managing Director of The Health Policy Partnership

VODI-section-pic-1440x960
Getting checked

Posted on 15.11.2019

Prevention is better than cure: it’s time we value diagnostic information

Prevention is better than cure. It’s cheaper too. In fact, preventing future illnesses and preventing complications from existing conditions, are vital to the future sustainability of health systems.  For a vaccine that prevents measles, or a medication that prevents a heart attack, the value is obvious. But what about the value of learning that you […]

By Hans Martens Chair of the Coalition for Health, Ethics and Society (CHES), and former CEO of the European Policy Centre (EPC)

shutterstock_573998317
Value

Posted on 03.10.2019

Training patients to engage in medtech R&D

The European Patients’ Academy (EUPATI) has trained dozens of patients to engage with companies and decision-makers on medicines development. Now it’s time to think about medtech. I am convinced that the days when experts and clinicians decided what patients want are long gone. Modern healthcare aspires to be patient-centred, while academics, policymakers and industry are […]

By Matthew May Programme Coordinator at EUPATI